New Insights into Aging: Which Aging Theory Prevails?
Read about groundbreaking research from UC San Diego linking genetic mutations and epigenetic changes, offering new insights into the molecular mechanisms of aging and reshaping future anti-aging strategies.
Xenon Gas: A Promising New Approach for Alzheimer’s Treatment
Discover how xenon gas, traditionally used as an anesthetic, shows promise in treating Alzheimer's disease by activating brain immune cells to reduce plaques and inflammation.
Can Nonagenarians Defy Cardiovascular Risks to Brain Health?
Research from UC Irvine questions traditional views on cardiovascular risks and brain health in individuals 90 and over.
The Impact of Nutrition on T Cell Fate and Exhaustion
Researchers at the Salk Institute have discovered that a switch from acetate to citrate as a nutritional source significantly influences T cell identity, particularly transforming active effector T cells into exhausted ones in chronic infections like cancer and HIV.
The Complexities and Risks of Microbiome Interventions for Children
Probiotics, touted for their health benefits, are raising FDA safety warnings and concerns about their use in infants, while regulatory challenges similarly impact fecal microbiota transplants (FMT). Consequently, medical professionals urge caution with probiotics and FMT in vulnerable groups, emphasizing potential risks over benefits.
Talking Real Science with Licy Yanes Cardozo
This episode of Share Science features Licy Yanes Cardozo, MD who shares with us her research focusing on the role and mechanisms by which androgen excess mediates cardiovascular disease in women
Industry Insights with Bas Trietsch and STEMCELL Technologies
Dr. Bas Trietsch and Dr. Jenna Moccia discuss stem cell-based models and organ-on-a-chip systems in this episode of Industry Insights.
Breakthrough CAR-T Cell Therapy Shows Promise Against Deadly Pediatric Brain Tumors
This article from GEN discusses recent successes in CAR-T cell therapy against solid pediatric tumors.
Relapse Prevention in Schizophrenia: Caplyta’s Clinical Trial Success
This article from Fierce Pharma discusses Intra-Cellular's recent clinical trial success with Caplyta for relapse prevention in schizophrenia.
Fruit Fly Research Unveils Potential Anti-Aging Strategies
This article from GEN discusses the impact that filamentous actin (F-actin) buildup has on the healthy aging of fruit flies.
IonOptix and Sarcometrics Announce Strategic Partnership
IonOptix and Sarcometrics announce a new strategic partnership combining IonOptix’s industry leading research instruments with Sarcometrics’ expertise in experimental design and data acquisition, analysis, and result interpretation.
Talking Real Science with Stella Goulopoulou
This episode of Share Science features Stella Goulopoulou, PhD who shares her research on preeclampsia and vascular physiology during pregnancy and why she’s passionate about women’s health.
Talking Real Science with Helen Collins
This episode of Share Science features Helen Collins, PhD who shares her research on cardiovascular risk and resilience in pregnancy and why she’s passionate about women’s health.
Talking Real Science with Rachel Buckley
This episode of Share Science features Rachel Buckley, PhD who shares her research on sex differences in Alzheimer's Disease and why she’s passionate about women’s health.
Nicotine Addiction Blocks Oxytocin’s Anxiolytic Effects on Stress
This study from Ren et al., investigates the interaction between oxytocin (OXT) and nicotine addiction in modulating psychosocial stress.
Hidden Consciousness in Unresponsive Brain Injury Patients
The first of its kind, an international study shows that approximately 25% of patients with severe brain injuries who appear physically unresponsive are actually conscious.
BioMarin Streamlines Pipeline, Discontinues Preclinical Gene Therapy BMN 293
BioMarin has decided to discontinue its preclinical gene therapy, known as BMN 293, which aims to treat myosin-binding protein C3 (MYBPC3) hypertrophic cardiomyopathy.
New CAR T Cell Therapy Shows Promise in Treating Aggressive Brain Cancers
Researchers at McMaster University recently discovered a signaling pathway -- known as PTP4A-ROBO1 -- that glioblastoma (GBM) cells exploit to invade the brain.
Critical Gatekeepers in Cancer Therapy and Prognosis, the Claudin Protein Family
The Claudin protein family is essential in tight junctions, regulating ion and water flow between cells and maintaining tissue integrity to prevent cancer cell migration.
Innovative Protein Mapping of Cerebral Spinal Fluid for Early Alzheimer’s Detection
A collaborative team of neuroscientists, biochemists, and Alzheimer's specialists from the United States and Icelandic institutions has developed a protein map to identify early markers for Alzheimer's disease in cerebrospinal fluid.
Cardiovascular Health Takes Center Stage in Dementia Risk Management
A recent publication from the University College London (UCL) show a shift in risk factors for dementia. By analyzing 27 studies spanning over 70 years, the authors identified cardiovascular health as a major emerging risk factor.
A Predictive Tool for Immunotherapy Response in Cancer Treatment
Chemotherapy, radiation, and surgical removal of tumors have long been standard cancer treatments. Identifying patients likely to benefit from these treatments remains a challenge.
Promising Advances in Lupus Treatment with CAR-T
Roberto Caricchio has been studying lupus for nearly three decades, observing slow progress in treatment. However, German scientists recently discovered that cellular medicines can drive lupus into remission, something that has been unable to be achieved with traditional drugs.
Neuralink’s First Recipient Noland Arbaugh
Noland Arbaugh is the first recipient of Neuralink's brain-computer interface (BCI) and reports no sensation of the device.
Advancing Cardiovascular Health Equity for LGBTQ+ Patients
LGBTQ+ populations have been demonstrated to require additional understanding into their unique health care needs, particularly their cardiovascular health.
